Prefoldin 5 inhibitors represent a class of chemical compounds designed to modulate the activity of prefoldin 5, a molecular chaperone essential for proper protein folding within the cell. Prefoldin 5, also known as PFDN5 or URI, plays a crucial role in facilitating the assembly of the tubulin and actin cytoskeletal components, thereby contributing to cellular structural integrity and stability. The inhibitors within this chemical class are specifically engineered to interfere with the normal functioning of prefoldin 5, ultimately disrupting its interactions with target proteins. By inhibiting prefoldin 5, these compounds may exert downstream effects on cellular processes reliant on the proper folding of key structural proteins.
Prefoldin 5 inhibitors involves binding to the active site or specific regions of prefoldin 5, hindering its ability to recognize and assist in the folding of substrate proteins. This interference can lead to misfolded or improperly assembled proteins, triggering cellular responses such as protein degradation or aggregation. As a consequence, the inhibition of prefoldin 5 by these compounds may have implications for cellular homeostasis, cytoskeletal organization, and overall protein quality control. Understanding the structural and functional aspects of prefoldin 5 inhibitors can provide valuable insights into the molecular intricacies of protein folding pathways and contribute to the development of targeted strategies for manipulating cellular processes in various biological contexts.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Binds to Hsp90, potentially disrupting its interaction with prefoldin complex, affecting PFDN5. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $130.00 $583.00 $4172.00 $20506.00 | 20 | |
Alters cytoskeletal organization, possibly impacting PFDN5's role in protein folding. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits protein synthesis, indirectly affecting proteins that may require PFDN5 for folding. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor, may alter gene expression of proteins interacting with PFDN5. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor, can affect degradation pathways of misfolded proteins involving PFDN5. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Affects Wnt signaling pathway, could indirectly affect protein folding processes involving PFDN5. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
Inhibits glycolysis, altering cellular metabolism which may impact PFDN5 function. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor, can affect protein synthesis pathways, indirectly touching upon PFDN5's role. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Modulates multiple signaling pathways, potentially altering PFDN5's protein folding environment. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Affects autophagy, which might influence the turnover of proteins involving PFDN5. | ||||||